2.3(top 20%)
impact factor
3.4K(top 5%)
papers
38.7K(top 10%)
citations
71(top 10%)
h-index
2.4(top 20%)
impact factor
4.2K
all documents
42.6K
doc citations
105(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1A Review of Cancer Immunotherapy: From the Past, to the Present, to the FutureCurrent Oncology2020554
2Oxaliplatin: A Review in the Era of Molecularly Targeted TherapyCurrent Oncology2011301
3Prophylaxis and Management of Acute Radiation-Induced Skin Reactions: A Systematic Review of the LiteratureCurrent Oncology2010276
4Advances in the Systemic Treatment of Triple-Negative Breast CancerCurrent Oncology2018241
5Immune Checkpoint Inhibitors in Cancer TherapyCurrent Oncology2022239
6Nonsurgical Treatment of Recurrent GlioblastomaCurrent Oncology2015228
7Microrna Let-7: An Emerging Next-Generation Cancer TherapeuticCurrent Oncology2010226
8Mindfulness-Based Stress Reduction for Breast Cancer—A Systematic Review and Meta-AnalysisCurrent Oncology2012205
9Optimal Chemotherapy Treatment for Women with Recurrent Ovarian CancerCurrent Oncology2007201
10Development of Cell-Cycle Inhibitors for Cancer TherapyCurrent Oncology2009201
11A Review of the Reliability and Validity of the Edmonton Symptom Assessment SystemCurrent Oncology2009198
12Anticancer Mechanisms of CannabinoidsCurrent Oncology2016192
13Exercise for People with Cancer: A Clinical Practice GuidelineCurrent Oncology2017189
14Symptom Clusters in Cancer Patients: A Review of the LiteratureCurrent Oncology2007188
15Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1Current Oncology2006182
16Current Management of Castrate-Resistant Prostate CancerCurrent Oncology2010180
17Survival of Patients with Non-Small-Cell Lung Cancer after a Diagnosis of Brain MetastasesCurrent Oncology2013171
18Gliadel Wafers in the Treatment of Malignant Glioma: A Systematic ReviewCurrent Oncology2007153
19Screening for Breast Cancer in 2018—What Should We be Doing Today?Current Oncology2018152
20Metronomic Chemotherapy: Changing the Paradigm That More Is BetterCurrent Oncology2009139
21Information Needs and Sources of Information for Patients during Cancer Follow-UpCurrent Oncology2014138
22How Effective Is Video Consultation in Clinical Oncology? A Systematic ReviewCurrent Oncology2010137
23Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1Current Oncology2006135
24Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working GroupCurrent Oncology2008127
25The Colon Health and Life-Long Exercise Change (CHALLENGE) trial (CO.21)Current Oncology2008124
26Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced DiarrheaCurrent Oncology2007124
27Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian RecommendationsCurrent Oncology2009120
28Complementary and Alternative Medicine Use in Patients Before and After a Cancer DiagnosisCurrent Oncology2018118
29Managing Treatment-Related Adverse Events Associated with egfr Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung CancerCurrent Oncology2011116
30Two Cases of Acrometastasis to the Hands and Review of the LiteratureCurrent Oncology2008115
31Treatment Paradigms for Patients with Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-LineCurrent Oncology2012114
32A Pan-Canadian Practice Guideline and Algorithm: Screening, Assessment, and Supportive Care of Adults with Cancer-Related FatigueCurrent Oncology2013112
33Use of Dexamethasone in Patients with High-Grade Glioma: A Clinical Practice GuidelineCurrent Oncology2014112
34Fine-Needle Sspiration Biopsy versus Core-Needle Biopsy in Diagnosing Lung Cancer: A Systematic ReviewCurrent Oncology2012110
35Current Landscape of Immunotherapy in the Treatment of Solid Tumours, with Future Opportunities and ChallengesCurrent Oncology2018109
36A New Standard of Care for the Management of Peritoneal Surface MalignancyCurrent Oncology2011108
37Has the Practice of Radiation Oncology for Locally Advanced and Metastatic Non-Small-Cell Lung Cancer Changed in Canada?Current Oncology2010107
38Management of Single Brain Metastasis: A Practice GuidelineCurrent Oncology2007104
39Connecting People with Cancer to Physical Activity and Exercise Programs: A Pathway to Create Accessibility and EngagementCurrent Oncology2018103
40Recurrent Nasopharyngeal Carcinoma: A Clinical Dilemma and ChallengeCurrent Oncology2013102
41Pheochromocytoma and paraganglioma syndromes: genetics and management updateCurrent Oncology2014102
42Exercise for People with Cancer: A Systematic ReviewCurrent Oncology2017100
43Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Brief ReviewCurrent Oncology201898
44Canadian Recommendations for the Treatment of Glioblastoma MultiformeCurrent Oncology200798
45High-Grade Hyperinvasive Sarcomatoid Urothelial Bladder Carcinoma Demonstrating Complete Response to Bladder-Preserving ChemoradiationCurrent Oncology200998
46Potential Use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic CancerCurrent Oncology201097
47Overcoming Endocrine Resistance in Hormone Receptor–Positive Breast CancerCurrent Oncology201896
48Novel Agents and Associated Toxicities of Inhibitors of the PI3K/Akt/mTOR Pathway for the Treatment of Breast CancerCurrent Oncology201595
49Integrating Cannabis into Clinical Cancer CareCurrent Oncology201695
50Denosumab and Giant Cell Tumour of Bone—A Review and Future Management ConsiderationsCurrent Oncology201394